Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Discovery | - | 15 Feb 2024 | |
Chronic idiopathic thrombocytopenic purpura | Discovery | - | 15 Feb 2024 | |
Endocrinology and Metabolic Disease | Discovery | - | 15 Feb 2024 | |
Endometriosis | Discovery | - | 15 Feb 2024 | |
Immune System Diseases | Discovery | - | 15 Feb 2024 | |
Irritable Bowel Syndrome | Discovery | - | 15 Feb 2024 | |
Labyrinth Diseases | Discovery | - | 15 Feb 2024 | |
Neoplasms | Discovery | - | 15 Feb 2024 | |
Nervous System Diseases | Discovery | - | 15 Feb 2024 | |
Other Diseases | Discovery | - | 15 Feb 2024 |